Robert Peter Budetti
Chief Executive Officer at Feighner Research Institute
Robert Peter Budetti active positions
| Companies | Position | Start | End |
|---|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Chief Operating Officer | 2010-02-04 | - |
| Feighner Research Institute | Chief Executive Officer | 2010-02-04 | - |
Career history of Robert Peter Budetti
Former positions of Robert Peter Budetti
| Companies | Position | Start | End |
|---|---|---|---|
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 1994-01-01 | 1994-01-01 |
| Institute for Creation Research | Chief Operating Officer | 1992-01-01 | 1992-01-01 |
| Director of Finance/CFO | 1992-01-01 | 1992-01-01 | |
| Founder | 1992-01-01 | 1992-01-01 |
Training of Robert Peter Budetti
| Harvard University | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Operating Officer | 2 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| Feighner Research Institute | |
| Institute for Creation Research | |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
- Stock Market
- Insiders
- Robert Peter Budetti
- Experience
